ライフサイエンスコーパス: partial protection

1 Par4(+/-) and P2ry12(+/-) mice showed partial protection.

2 however, the 2/3 running group demonstrated partial protection.

3 , c-SRC, or YES each provided comparable but partial protection.

4 methyl ester hydrochloride (L-NAME) afforded partial protection.

5 ency of RIP3 (also known as RIPK3) conferred partial protection.

6 ylic acids, glutathione and catalase yielded partial protection.

7 inistration of exogenous MT protein afforded partial protection.

8 , whereas a liquid formulation provided only partial protection.

9 mary tumors, whereas CD4(+) T cells revealed partial protection.

10 and a RT inhibitor, azidothymidine, provided partial protection.

11 immunized at 4 years of age gave complete or partial protection.

12 ll protection provided stronger effects than partial protection.

13 single immune parameter was associated with partial protection.

14 , whereas cloned CD4+ T cells conferred only partial protection.

15 after IL-3 withdrawal, although IRS-1 offers partial protection.

16 icacy trial can help elucidate mechanisms of partial protection.

17 NCDV-immunized mice also showed partial protection.

18 ed by some stockpiled vaccines, confers only partial protection.

19 617.2 variant, whereas rVSV-S only conferred partial protection.

20 es, and first generation vaccines offer only partial protection.

21 MyD88, while deletion of Trif provided only partial protection.

22 Dll1 or Dll4 inhibition alone provided partial protection.

23 et of UVR-driven melanoma, but only provided partial protection.

24 hereas subcutaneous vaccination induced only partial protection.

25 etween MHC class II alleles and solid versus partial protection.

26 The thioester compound TC247 offered partial protection.

27 Partial protection (2 of 4 animals) by MIV-150-carrageen

28 n EIII/JC inbred rabbits (100%) and provided partial protection (55%) against virus challenge in outb

29 mplete protection against s.c. challenge and partial protection (70% survival) against pulmonary chal

30 ective than HF5 and CD6, as indicated by the partial protection achieved even at doses as high as 15

31 Partial protection after challenge was not associated wi

32 nal scores indicated that GDNF provided only partial protection against 6-OHDA neurotoxicity in terms

33 Partial protection against a challenge with NFSA(MART1)

34 an immunodeficiency virus infection confers partial protection against a second immunodeficiency vir

35 s with an rD15 vaccine preparation conferred partial protection against a virulent challenge infectio

36 Further, the partial protection against a virulent, pathogenic SIV ch

37 The latter also displayed partial protection against Abeta-induced cell death and

38 on (IL-4/IL-5/IL-12(p70)/IL-13/GM-CSF) and a partial protection against airway hyperresponsiveness.

39 dengue vaccine candidate, demonstrated only partial protection against all four DENV serotypes, desp

40 ice and mice treated with JNK2 ASO exhibited partial protection against APAP.

41 -associated protein 1 (RAP-1), which confers partial protection against B. bovis challenge, is recogn

42 ogen can induce specific CTLs able to confer partial protection against bacterial challenge.

43 In addition, Bax deficiency only provides partial protection against camptothecin and cisplatin-in

44 cquired IL-17-producing ability and provided partial protection against Candida albicans.

45 conclude that the water channel AQP4 confers partial protection against cerebral malaria.

46 viously shown that B. bigemina RAP-1 induced partial protection against challenge infection.

47 demonstrated that this regimen could provide partial protection against challenge with chimeric P. be

48 Eighteen of the individual Ags conferred partial protection against challenge with virulent Mtb.

49 er challenge, and (iii) immunization induced partial protection against challenge; however, protectio

50 Pre-existing MNV-specific Trm cells provided partial protection against chronic infection but largely

51 otection was seen against clades A and C and partial protection against clade G gag-expressing rVV.

52 vaccine termed RTS,S but this provides only partial protection against clinical disease.

53 and HIV-infected pregnant women and provided partial protection against confirmed influenza in both g

54 doses of RTS,S/AS01 malaria vaccine provides partial protection against controlled human malaria para

55 rabbit papillomavirus (CRPV) E6 gene induced partial protection against CRPV challenge and that the v

56 A and DeltaaroD SCHU S4 derivatives provided partial protection against death (27 to 36%) and a prolo

57 , mice vaccinated with ALM/rIL-12 maintained partial protection against dermal lesions and their para

58 s for the prevention of malaria provide only partial protection against disease due to high variabili

59 However, Lcn2 retained partial protection against disseminated disease.

60 ations did not aggregate in saline, provided partial protection against DNase I digestion and exhibit

61 ta-hydroxybutyrate (DbetaHB) in mice confers partial protection against dopaminergic neurodegeneratio

62 vulina, which was previously shown to confer partial protection against E. acervulina challenge when

63 cination did prime these Th2 cells rendering partial protection against EAE challenge.

64 We demonstrate partial protection against EBOV by a single-shot Ad26 va

65 Finally, DC-based immunization also afforded partial protection against established B16 tumor cells,

66 Inhibition of JNK activity in vitro provided partial protection against ethanol neurotoxicity.

67 unogenic for T cells and capable of inducing partial protection against experimental malaria challeng

68 Currently, autogenous vaccines provide partial protection against furunculosis, but their effic

69 ococcus serogroup B (MenB) vaccines provided partial protection against gonococcal infection.

70 can be learned about the 4CMenB vaccine with partial protection against gonorrhea, doxycycline postex

71 genotype vaccine construct may have elicited partial protection against HCMV viruses with antigenical

72 vector induces humoral immunity and confers partial protection against heterologous challenge.

73 Partial protection against heterologous influenza virus

74 vaccine alone, without LT(R192G), displayed partial protection against heterosubtypic challenge.

75 ll mediated immunity and was associated with partial protection against high-dose intrarectal SIV(mac

76 d leptin sensitivity in the hypothalamus and partial protection against high-fat diet (HFD)-induced o

77 IV-1 infection in homozygous individuals and partial protection against HIV disease progression in he

78 R5 Delta 32 heterozygous genotype may confer partial protection against HIV-1 infection in women.

79 32 genotype in heterosexual sex partners and partial protection against HIV-1 infection, and they emp

80 st, a polyclonal HIV-1 Ig fraction exhibited partial protection against HIV-1(LAI) at 150 mg/kg but n

81 oteins have been shown to induce complete or partial protection against homologous challenge.

82 n with recombinant AceKI was shown to confer partial protection against hookworm-associated growth de

83 rPSGL-Ig provides partial protection against I/R injury to ex vivo rat liv

84 ino-1-naphthalene sulfonate (ANS) each yield partial protection against inactivation and decrease rea

85 munity to seasonal coronaviruses may provide partial protection against infection with severe acute r

86 h the DeltarelA DeltaspoT mutant resulted in partial protection against infection with wild-type B. p

87 tion of at-risk groups and children offering partial protection against infection.

88 MSP-3, which were previously shown to induce partial protection against infection.

89 administration of recombinant CD40L provided partial protection against infection.

90 ted animals to infectious HIV-1 demonstrated partial protection against infectious HIV-1 challenge.

91 against cytomegalovirus (CMV) provides only partial protection against intrauterine transmission of

92 2+) in postischemic CA1 neurons and afforded partial protection against ischemia-induced cell death.

93 with individual single protein VLPs provides partial protection against lethal respiratory infections

94 g/kg x 4 days in a murine model and provided partial protection against liver stage Plasmodium berghe

95 4 days or 80 mg/kg x 1 day and also provided partial protection against liver-stage Plasmodium berghe

96 advanced vaccine candidate, RTS,S, conferred partial protection against malaria in phase II clinical

97 n erythrocyte invasion may contribute to the partial protection against malaria that is acquired duri

98 iferation in response to MCMV infection, and partial protection against MCMV.

99 ulated genes, including SCD, which conferred partial protection against NAMPT inhibitors.

100 V-1 vaccine candidates have previously shown partial protection against neutralization-resistant viru

101 tibody, which upon passive transfer provided partial protection against P. chabaudi challenge, sugges

102 MVA encoding ME-TRAP but not CS resulted in partial protection against P. falciparum sporozoite chal

103 utralized sporozoites in vitro and conferred partial protection against P. falciparum sporozoite infe

104 In addition to providing partial protection against pediatric tuberculosis, vacci

105 e subdominant epitopes, GP283-291, conferred partial protection against persistent viral infection af

106 Whereas LcrV immunization resulted in partial protection against pneumonic plague challenge wi

107 protein B-specific IgG may contribute to the partial protection against postnatal CMV infection affor

108 V or PRV, whereas HRV Wa G1P[8] induced only partial protection against PRV challenge.

109 n against rechallenge with WA1/2020 but only partial protection against rechallenge with B.1.351.

110 e incorporating molecular adjuvants mediated partial protection against rectal SIVmac251 challenges.

111 inst TCDD-induced pericardial edema and show partial protection against reduced blood flow and cranio

112 gocytophilum in white-footed mice results in partial protection against reinfection with the same age

113 cytophila in white-footed mice provided only partial protection against reinfection with the same age

114 role in viral clearance as well as providing partial protection against reinfection.

115 SARS-CoV-2 is weakly immunogenic and confers partial protection against respiratory SARS-CoV-2 challe

116 imulatory cytokine interleukin-12 results in partial protection against RH lethal challenge.

117 G-CSF deficiency also provided partial protection against ROP.

118 immunoglobulin G titers were associated with partial protection against rotavirus infection.

119 Although CVnCoV provided partial protection against SARS-CoV-2 challenge, CV2CoV

120 When overproduced alone, YknW provides partial protection against SDP toxin, but all four Ykn p

121 strate that treatment with oral TDF provided partial protection against SHIV infection but ultimately

122 e most robust protective signatures provided partial protection against SIVmac251 challenges in naive

123 small amount of normal XPC mRNA can provide partial protection against skin cancers.

124 yoelii merozoite surface protein 1 provided partial protection against sporozoite challenge and resu

125 using alternative-serotype Ad vectors confer partial protection against stringent simian immunodefici

126 Partial protection against subsequent tumor challenges w

127 Galphai2 deficiency in erythrocytes confers partial protection against suicidal cell death.

128 d an adaptive immune response that conferred partial protection against SVV challenge.

129 te-Guerin (BCG) vaccination, known to induce partial protection against TB, was used as a model syste

130 DHBP (20-100 microM) also gave partial protection against TG toxicity, as did ruthenium

131 inhibitors K252a and staurosporine provided partial protection against the effects of calyculin A.

132 observed on the normal diet may underlie the partial protection against the elevated serum glucose an

133 s produced by AMPS-BDB, while ADP gives only partial protection against the inactivation.

134 ombination with CD28 or CD28 plus CD40) gave partial protection against the inhibitory effect of tran

135 ntified as a proapoptotic molecule, afforded partial protection against TNFalpha-induced apoptosis.

136 ore, these tumor-specific antibodies provide partial protection against tumor challenge.

137 MPXV antigen-encoding mRNA vaccines provided partial protection against VACV challenge, whereas multi

138 urthermore, Hif2a heterozygosity resulted in partial protection against vascular remodeling, hemorrha

139 ace infection of worms with Verde1 conferred partial protection against Verde2.

140 HIV-1 and SIV vaccine candidates have shown partial protection against viral challenges in rhesus ma

141 lizing antibodies to SHIV-89.6 that provided partial protection against viremia following SHIV-89.6 i

142 This regimen induced partial protection against virus shedding (58%) and diar

143 eutralizing antibody responses and exhibited partial protection against virus shedding in the lungs c

144 d DNA vaccines expressing NS1, alone, confer partial protection against ZIKV infection in both immuno

145 nd T cell immune responses but provided only partial protection against ZIKV viremia in BALB/c mice.

146 on of B cell knockout (BKO) mice resulted in partial protection, and complete protection was reconsti

147 Recent phase III vaccine trials showed partial protection, and in particular no protection for

148 NMDA receptor blockers individually provided partial protection, and the combination was fully protec

149 ycobacterium bovis BCG vaccine provides only partial protection, and the skin test reagent used to ai

150 ntrations of ribonuclease T1, two regions of partial protection are seen.

151 We interpret these regions of partial protection as defining two RNA product binding s

152 ation using monoclonal antibody M131 conveys partial protection as evidenced by significant lesion de

153 ctivity between influenza strains conferring partial protection as high as 55%.

154 MPV.A4 also offers partial protection at 6 h post-viral inoculation in fema

155 malaria vaccine, RTS,S/AS01 (RTS,S), confers partial protection but with antibody titers that wane re

156 Bicuculline exerted partial protection (by 30%) while GABA reduced bilobalid

157 IM, or simian strain RRV was associated with partial protection, characterized by reduced viral shedd

158 istinct molecular signatures associated with partial protection, complete protection, and the contrib

159 ced V2 responses plausibly had a role in the partial protection conferred by the RV144 regimen.

160 equivalent ratio of Hc1/DNA (10:1), there is partial protection conferred upon Hc1 to an extent that

161 ventive treatment in infants provides modest partial protection, consistent with the rationale of the

162 dividual serotype M. catarrhalis only showed partial protection coverage.

163 As such, the partial protection elicited by VraA immunization provide

164 s of bcl-xL in control cells but did provide partial protection for the loss of the transfected form,

165 Both IFA and CFA, however, provided partial protection from a challenge with infectious H. p

166 ivity in primary-infected mice, or (iii) the partial protection from a secondary vaginal infection un

167 EC to interleukin (IL)-13 for 72 hr afforded partial protection from apoptosis induced by tumor necro

168 activated by NF-kappaB via IKKbeta, provides partial protection from apoptosis.

169 y, 61% of large neurons survived, indicating partial protection from atrophy.

170 regulation in vivo and in vitro, and confers partial protection from bleomycin-induced scleroderma in

171 d that the IL-15 mutant/Fc treatment confers partial protection from both CD4(+) and CD8(+) T cell gr

172 ignificant decline in Bax protein levels and partial protection from CD40-mediated death, indicating

173 ies (ROS), and antioxidant treatment imparts partial protection from cell death, suggesting that ROS

174 xcellent protection from acute infection and partial protection from chronic infection in an immunoco

175 nistered to MDA-positive pigs still provided partial protection from CO99 and may be a safer vaccine

176 ed up-regulation of claudin-5 expression and partial protection from cytotoxicity.

177 enetic deletion of Caspase-6 indeed provides partial protection from degeneration.

178 s of Idd3 and Idd10 individually confer only partial protection from diabetes but, in combination, re

179 d chromosome termini provide the A line with partial protection from end-joining repair activities, t

180 nce of anti-inflammatory cytokines, but only partial protection from endotoxic shock.

181 y defects in downstream T-cell responses and partial protection from experimental autoimmune encephal

182 ency of the common TLR adaptor MyD88 offered partial protection from Foxp3 deficiency disease.

183 hookworm antigens emulsified in alum led to partial protection from hookworm-associated pathology in

184 l vaccines that, by themselves, provide only partial protection from infection.

185 Animals that were deficient in C3 had partial protection from IRI induced by 27.5 min of bilat

186 hondrial Ca(2+) uptake in cardiomyocytes and partial protection from ischemia-reperfusion injury by r

187 ancestral and JN.1 strains, and M39 offered partial protection from JN.1.

188 uppress AhR activity provided wild-type mice partial protection from Jo2-induced lethality.

189 /New Caledonia/20/99 H1N1 vaccines displayed partial protection from lethal challenge.

190 fection with WN virus to naive mice afforded partial protection from lethal infection.

191 le virus reduced the viral load and afforded partial protection from lethal infection.

192 dendrimer coating, Ad5-CMV/NIS demonstrated partial protection from neutralizing antibodies and enha

193 on of fecal IgG was associated with total or partial protection from oral challenge with ALA rotaviru

194 A4(1) demonstrated partial protection from paralysis in a murine model of p

195 ses this issue, whereas cousins provide only partial protection from population stratification.

196 97 led to a reduction of ATPase activity and partial protection from proteolysis.

197 NA co-aggregates with rPrP and thereby gains partial protection from RNase digestion.

198 and combined ("hybrid immunity"), result in partial protection from subsequent infection and strong

199 in vivo model of poliomyelitis demonstrated partial protection from the onset of paralysis.

200 n-specific Cys529 variant apparently confers partial protection from the severest virus-induced asthm

201 fects of chemically generated NO or H202 and partial protection from their cytolytic effects.

202 o-edged role in HIV-1 infection: it afforded partial protection from viral infection, but during infe

203 CMV entry, glycoprotein B (gB), demonstrated partial protection in a clinical trial when delivered wi

204 identified from our kinome analysis provided partial protection in a lethal model of EBOV infection.

205 ne in development, RTS,S/AS01, provided only partial protection in a Phase 3 trial.

206 effectiveness is stable and vaccine provides partial protection in all vaccinees ("leaky") rather tha

207 (50), 20 +/- 3.4 micromol/L) and conferred a partial protection in cells exposed to micromolar CCI-77

208 The blocking of caspases provides only partial protection in experimental meningitis, which sug

209 CD40+ lymphomas (A20, A31 and BCL1) and gave partial protection in one of two CD40- lymphomas (EL4 an

210 thiocyanate extracts of P. multocida induces partial protection in rabbits.

211 T cell- or CD8(+) T cell-deficient mice and partial protection in T cell-deficient mice but did not

212 al adjuvant cholera toxin were afforded only partial protection in that primary lesions were observed

213 Moreover, these gangliosides conferred partial protection in the context of bacterial infection

214 rotection in the upper respiratory tract and partial protection in the lungs.

215 at vaccination before infection confers only partial protection in the post-acute phase of the diseas

216 -type animals were observed in the liver and partial protection in the spleen.

217 challenge in the lower respiratory tract and partial protection in the upper respiratory tract.

218 CD8 T cells provide partial protection in this model, and tumors from sepsis

219 or disease due to the vaccine, the degree of partial protection in those still susceptible, and the a

220 (2) Is partial protection induced by an HIV vaccine adequate to

221 Partial protection is afforded by the addition of 0.4 M

222 The partial protection likely allows the acceptor RNA to mor

223 accines, provided inferior immunity and only partial protection (</=40%).

224 r recombinant MVA vaccine alone, and produce partial protection manifest as delayed parasitemia after

225 rotype against which the vaccine offers only partial protection may initially increase and then decre

226 One commercial vaccine provided partial protection measured by reduced nasal shedding; h

227 oviders had misperceptions about the limited/partial protection medical male circumcision offers.

228 RM-3 given 3 days after collagenase afforded partial protection, modulated inflammation, and decrease

229 ulation with glutamate, in contrast with the partial protection observed in cells overexpressing TrkB

230 as no significant difference in the level of partial protection observed in the homologous and hetero

231 rotected against homologous challenge, while partial protection occurred following heterologous chall

232 Partial protection occurs in PARP +/- animals.

233 ve fibres induced by paclitaxel and provided partial protection of axonal function assessed by sensor

234 o demonstrated that LeIF was able to provide partial protection of BALB/c mice against L. major.

235 of infected hepatocytes in vitro, as well as partial protection of BALB/c mice against sporozoite cha

236 5 degrees C in which GroES addition leads to partial protection of bound DHFR.

237 The partial protection of CD3(-) FAS(-) allo-CAR T cells fro

238 a-producing Th1 cells may be responsible for partial protection of CD4(+) T cells against the mammary

239 ction of either gammaD364H or gammaD364V but partial protection of gammaD364A, indicating the peptide

240 ce three times with cDNA encoding VP2 led to partial protection of mice from CNS demyelinating diseas

241 251 intravaginal exposures again resulted in partial protection of one of two immunized macaques, man

242 interleukin-12 along with virus resulted in partial protection of PE mice and provided complete prot

243 Finally, partial protection of RPMI 8226 cells against the imexon

244 estimated and likely an evidence of at least partial protection of the population at risk through rin

245 teinase or other available nucleophiles, and partial protection of the proteinase against macromolecu

246 matin, however, DNase I hypersensitivity and partial protection of the regulatory motifs from DNase I

247 otection of the putative Sp1 cis-element and partial protection of the sequence defined as X-NotI in

248 n of arsenic by the liver, thereby providing partial protection of the whole animal from arsenic toxi

249 n the denatured state, likely due to full or partial protection of these residues as folding occurs.

250 p21 expression resulted in a consistent, but partial, protection of cells from undergoing IR-induced

251 We evaluated the impacts of full and partial protection on biomass and density of fish assemb

252 linical isolate of M. tuberculosis conferred partial protection on mice after respiratory challenge (

253 even TILN-immunized macaques showed total or partial protection (P = 0.001).

254 protective immunity is slow to develop, and partial protection requires years of repeated exposure.

255 Our formulations conferred partial protection (significant delay in the time to rea

256 To increase the number of individuals with partial protection, some governments are considering del

257 In vitro phage-lysed bacteria provide partial protection, suggesting a combination of phage-in

258 Over all, Sal-Ag vaccine imparted partial protection that limited colonization in tissues

259 immunity following repeated reexposures; 2) partial protection that wanes over time; or 3) full but

260 8+ lymphocyte effectors capable of mediating partial protection through IFN-gamma secretion.

261 function, whereby its expression can impart partial protection to cultures from selected antibiotics

262 that these cross-reactive CTL might provide partial protection to humans against novel influenza A v

263 idant and mitochondrial function, indicating partial protection to IAV infection.

264 e 110 offered excellent potency and provided partial protection to leishmania-infected mice at 40 and

265 NAI, compounded by a subpopulation with only partial protection to malaria, may render vaccination ef

266 ng retroviral infection in vivo and provides partial protection to mice against infection with mouse

267 However, passive transfer of partial protection to naive IL-4Ralpha(-/-) mice, using

268 d adoptive transfer of immune sera conferred partial protection to naive mice.

269 rum from Bp82-vaccinated mice could transfer partial protection to nonvaccinated animals.

270 restingly, serum from naive WT mice provided partial protection to PI3Kd(D910A) mutants, indicating a

271 herapy of tumors with mutant p53 may offer a partial protection to proliferating normal tissues.

272 ty in the host provided protection, at least partial protection, to new variants.

273 Both transgenic mice showed partial protection toward Aldara-induced inflammation co

274 in which p21 expression was restored enjoyed partial protection under these conditions.

275 Complete and partial protection was achieved with a single dose given

276 Partial protection was achieved with the lower PIZV dose

277 In the absence of interferon treatment, partial protection was characterized by the generation o

278 g rickettsial proliferation in vivo, whereas partial protection was observed in mice receiving lipopo

279 r during a secondary vaginal infection where partial protection was observed.

280 gnitude but similar response associated with partial protection was seen in mice that received a dose

281 Reduced viral loads and partial protection were observed in animals given MAbs c

282 of 10(2) HAD50 of ASFV-G-Delta9GLv conferred partial protection when pigs were challenged at either 2

283 Interestingly, males displayed partial protection when they received MPV.A4 at the time

284 weekly at 10 mg/kg provides significant but partial protection, while biweekly 50 mg/kg provides com